Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Dexmedetomidine to 20ml Bupivacaine in Supraclavicular Brachial Plexus Block

NCT06020781 is registered in ClinicalTrials.gov with Kafrelsheikh University as lead sponsor.

NCT NCT06020781
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06020781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Dexmedetomidine to 20ml Bupivacaine in Supraclavicular Brachial Plexus Block
Lead sponsor
Kafrelsheikh University
Phase
Not applicable
Overall status
Completed
Start date
October 9, 2023
Completion date
March 11, 2024
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bupivacaine, dexmedetomidine, supraclavicular brachial plexus block